This is a community-generated profile. If you would like to claim it, please .
Sutro Biopharma Funding
$116.3M
77 rounds
Sutro Biopharma is active in the following markets / industries: biotechnology. The company has secured funding across 7 rounds, totaling in an amount of $116.3M. Their most recent funding was raised on December 11, 2013.
Funding Rounds
D
$26000000Series DDec 2013
+2
C
$16500000Series CMay 2012
+1
C
$36500000Series CNov 2010
+1
B
$15000000Series BMar 2009
B
$21000000Series BDec 2007
U
$305000UnknownOct 2007
A
$1000000Series AJan 2006
Investors of Sutro Biopharma
Patricia Sinatra
Exec roles ranging from SmithKline (merged with GSK); Abgenix (Acquired by Amgen); Matrix (acquired by Chiron/Novartis); SutroBio and others.
International Biotechnology Trust
Amgen Ventures
Celgene
Rounds
D
Skyline Ventures
Rounds
D
C
C
Alta Partners
Rounds
D
C
C
B
B
Amgen
Rounds
D
C
C
SV Life Sciences
Rounds
D
C
C
B
B
U
A
Lilly Ventures
Rounds
C
C